For Release

January 29, 1996 AAAAI

American Academy of Allergy, Asthma and Immunology
611 E. Wells Street
Milwaukee, WI 53202-3889

Contact: Linda Bleimehl
Fax 414/272-6070

Below are highlights of studies published in the December 1995 issue of the Journal of Allergy and Clinical Immunology, the peer-reviewed, scientific journal of the American Academy of Allergy Asthma & Immunology (AAAAI). The full text of these studies may be obtained through the AAAAI public relations office.


MILWAUKEE - Doctors from Alfred Hospital in Victoria, Australia, recently reported seven cases of royal jelly-induced asthma and anaphylaxis. Royal jelly is a secretion of the hypopharyngeal glands of young worker honeybees and is widely sold in health food stores as a health tonic. According to the physicians, clinical studies confirm that the cases were true allergic reactions. All of the seven patients had a history of mild to moderate asthma and gave a clear history of reactions temporally related to the intake of royal jelly. Of particular interest, note the physicians, is the "immunologic recognition" of royal jelly proteins by antibodies in sera from a number of patients with bee venom sensitivity and other common allergic disorders. "This finding could imply that there are many 'sensitized' individuals at risk for adverse reactions when exposed to royal jelly," the physicians note. "Alternatively, it could indicate mere cross-reactivity between royal jelly antigen with commonly occurring environmental allergens."

The AAAAI is the largest national medical organization representing allergists, clinical immunologists, and allied health professionals. Established in 1943, the Academy has more than 5,000 members in the United States, Canada, and 41 other countries.


EDITOR'S NOTE: These studies were published in the peer-reviewed, scientific journal of the AAAAI, but do not necessarily reflect the policies or opinions of the AAAAI.

[Return to News Release Index]